Fuse Medical Stock Revenue
| FZMD Stock | USD 0.12 0.07 140.00% |
Fuse Medical fundamentals help investors to digest information that contributes to Fuse Medical's financial success or failures. It also enables traders to predict the movement of Fuse Pink Sheet. The fundamental analysis module provides a way to measure Fuse Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Fuse Medical pink sheet.
Fuse |
Fuse Medical Company Revenue Analysis
Fuse Medical's Revenue is income that a firm generates from business activities such us rendering services or selling goods to customers. It is a crucial part of a business and an essential item when evaluating a company's financial statements. Revenues from a firm's primary business operations can be reported on the income statement as sales revenue, net sales, or simply sales, depending on the industry in which a given company operates.
Current Fuse Medical Revenue | 20.41 M |
Most of Fuse Medical's fundamental indicators, such as Revenue, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Fuse Medical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Revenue is typically recorded when cash or cash equivalents are exchanged for services or goods and can include products or services discounts, promotions, as well as early payments on invoices or services rendered in advance.
| Competition |
Based on the latest financial disclosure, Fuse Medical reported 20.41 M of revenue. This is 99.73% lower than that of the Health Care Providers & Services sector and 99.2% lower than that of the Health Care industry. The revenue for all United States stocks is 99.78% higher than that of the company.
Fuse Revenue Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Fuse Medical's direct or indirect competition against its Revenue to detect undervalued stocks with similar characteristics or determine the pink sheets which would be a good addition to a portfolio. Peer analysis of Fuse Medical could also be used in its relative valuation, which is a method of valuing Fuse Medical by comparing valuation metrics of similar companies.Fuse Medical is currently under evaluation in revenue category among its peers.
Fuse Fundamentals
| Return On Asset | -0.0331 | |||
| Profit Margin | (0.04) % | |||
| Operating Margin | (0.05) % | |||
| Current Valuation | 12.09 M | |||
| Shares Outstanding | 72.9 M | |||
| Shares Owned By Insiders | 88.44 % | |||
| Price To Sales | 0.57 X | |||
| Revenue | 20.41 M | |||
| Gross Profit | 11.94 M | |||
| EBITDA | (1.42 M) | |||
| Net Income | (1.59 M) | |||
| Cash And Equivalents | 604 K | |||
| Cash Per Share | 0.01 X | |||
| Total Debt | 200 K | |||
| Debt To Equity | 106.80 % | |||
| Current Ratio | 1.15 X | |||
| Book Value Per Share | (0.06) X | |||
| Cash Flow From Operations | (1.78 M) | |||
| Earnings Per Share | (0.02) X | |||
| Number Of Employees | 14 | |||
| Beta | 0.71 | |||
| Market Capitalization | 9.84 M | |||
| Total Asset | 18.3 M | |||
| Retained Earnings | (2.8 M) | |||
| Working Capital | 2.31 M | |||
| Current Asset | 2.31 M | |||
| Current Liabilities | 2.14 K | |||
| Z Score | 30.4 | |||
| Net Asset | 18.3 M |
About Fuse Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Fuse Medical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Fuse Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Fuse Medical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Other Information on Investing in Fuse Pink Sheet
Fuse Medical financial ratios help investors to determine whether Fuse Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Fuse with respect to the benefits of owning Fuse Medical security.